Valbenazine tosylate, a benzoquinolizidine derivative, is a highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor. It is the first and the only drug approved by the FDA for the treatment of tardive dyskinesia. Rapid, sensitive, and cost-effective first-order derivative UV spectrophotometric methods have been developed for the estimation of valbenazine in bulk and in its marketed formulation. Preliminary spectrophotometric determination of the drug was carried out in acetonitrile and in 0.1 N HCl with a total of 19 parametric variations for the two methods. The selected three-method variants employing peak–zero (P–0) and peak–peak (P–P) techniques were assessed for their stability, indicating potential in force degraded solutions of the drug. The developed methods were validated with respect to linearity, accuracy, precision, and robustness. Linearity was observed within the concentration range 5.0–70.0 μg/mL with an excellent correlation coefficient (r2) of 0.9998. The limits of assay detection values for the proposed method variants were found to range from 0.89 to 2.75 μg/mL, and quantitation limits ranged from 1.19 to 4.32 μg/mL. The proposed methods were applied for the determination of the drug in its marketed capsule formulation, and percentage recovery was found to range from 94 to 95%.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
https://pubchem.ncbi.nlm.nih.gov/compound/92042922#section=Top (Last accessed: January 2022).
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/2092 41lbl.pdf (Last accessed: 24 February 2022).
H. Gupta, A. R. Moity, A. Jumonville, S. Kaufman, A. N. Edinoff , and A. D. Kaye, Health Psychol. Res., 9, No. 1, Article ID 24929 (2021).
D. E. Grigoriadis, E. Smith, S. R. Hoare, A. Madan, and H. Bozigian, J. Pharm. Exp. Therap., 361, No. 3, 454–461 (2017).
R. K. Narsi, B. David, J. F. Otilia, R. P. Jyothi, and M. Swetha, Int. J. Pharm. Sci. Rev., 4, 104–114 (2010).
S. Uhlyar and J. A. Rey, Pharm. Therap., 43, No. 6, 328–331 (2018).
P. Imam, S. Ahsan, B. Murali, and A. Koneru, World J. Pharm. Res., 7, No. 18, 948–963 (2018).
P. J. Parmar, V. B. Patel, and D. A. Shah, Sep. Sci. Plus, 3, No. 4, 94–101 (2020).
Y. M. Zhang, L. I. Xin, Y. U. Da-Wei, Y. Sun, L. I. U. Xing-Hua, and W. Y. Xing-Hua, J. Chin. Mass Spectrom. Soc., 43, No. 1, 78 (2022).
ICH, Validation of Analytical Procedures: Text and Methodology Q2 (R1), Int. Conf. Harmonization, Geneva, Switzerland, 11, 1–13 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
Abstract of article is published in Zhurnal Prikladnoi Spektroskopii, Vol. 90, No. 4, p. 658, July–August, 2023.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gupta, T., Bali, A. & Mahesh, M. Stability Indicating Derivative Spectrophotometric Methods for Determination of Valbenazine Tosylate in Bulk and in Formulation. J Appl Spectrosc 90, 900–906 (2023). https://doi.org/10.1007/s10812-023-01612-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10812-023-01612-9